rolithin A pharmacokinetic trial - Urolithin A pharmacokinetic trial

Shinanozaka Clinic0 个研究点目标入组 30 人开始时间: 2021年1月14日最近更新: 2023年10月17日

试验速览

暂无简介。

•1) Those who are treated by a doctor or dentist 2) Persons with or have a history of hypersensitivity or idiosyncrasy to drugs or food 3) Person with allergic diseases such as bronchial asthma, hay fever, and atopic dermatitis 4) Those who have diseases in the heart, liver, kidney, digestive organs, respiratory organs, blood function, etc., or those who have a history of them or have a large surgical history, and are not eligible for this study by the investigator Those who are judged to be (excluding appendectomy) 5) Those who are or may be allergic to ellagic acid-containing foods (pomegranates, berries, nuts, etc.) 6) Those who are confirmed to be positive in the immunological test at the time of screening test 7) Person who regularly use foods for specified health use, foods with functional labeling foods and dietary supplements (supplement foods such as capsules) and cannot stop their intake at the time of obtaining consent. 8) Those who cannot keep smoking cessation during the period of admission and prohibition of drinking from 2 days before admission to the time of leaving 9) Those who cannot comply with not taking from ingesting ellagic acid-containing foods (pomegranates, berries, nuts, etc.) from 7 days before entering the hospital until leaving the hospital. 10) Those who have used or took the drug within 1 week before ingesting the test food, or those who need to use or take the drug

发起方

Shinanozaka Clinic